Breakthrough: Pfizer's Vaccine & “A Great Day for Humanity” with CEO Albert Bourla

Squawk Pod

CNBC

Business News, Investing, Business, News

4 • 494 Ratings

🗓️ 9 November 2020

⏱️ 38 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In what Pfizer CEO Albert Bourla calls “likely the most significant medical advancement in the last 100 years,” BioNtech and Pfizer’s Covid-19 vaccine may prove to be more than 90% effective in preventing coronavirus. CNBC’s Senior Health and Science Reporter Meg Tirrell breaks the good news with the Squawk Box anchors, and Pfizer CEO Dr. Albert Bourla discusses the success, the implications, and the questions still unanswered. In an extended interview, Bourla thanks his scientists for their ongoing work to change the course of history and outlines the road ahead.

Transcript

Click on a timestamp to play from that location

0:00.0	This is Squawk Pod. I'm C. NBC producer Katie Kramer. Today on our podcast Light at the end of the tunnel.
0:09.0	Pfizer says its COVID-19 vaccine candidate may be more than 90% affected at preventing the coronavirus.
0:16.2	The company's CEO shares this watershed moment.
0:19.4	It is a great day for science.
0:22.2	It is a great day for humanity. I think we can see light at the end of the time.
0:27.0	After months of thinking the days of travel and hugs were behind us, the world can hope for normal again.
0:33.4	I believe this is likely the most significant medical advance in the last hundred years.
0:38.4	While we have a long way to go in ending this pandemic, Pfizer's Dr. Albert Borla says for the moment we should enjoy relief.
0:46.2	Sometimes I have tears in my eyes. I think the most important thing right now for everyone it is to feel the joy that it happened and it
0:55.3	happened so well. Our own Joe Kernan certainly is. I woke up to a horse
0:59.7	scope that said you may be rather emotional about something today.
1:02.7	I swear to God.
1:04.4	It's Monday, November 9, 2020, Squackpot from CNBC.
1:17.0	Welcome back to Squawk Box everybody.
1:21.0	We have some breaking news from Pfizer.
1:24.0	Megg Terrell joins us right now. Megg good morning.
1:26.4	Good morning, Becky. This is the news that we've been waiting to hear.
1:29.5	Pfizer and Biontag reporting the first results from their phase 3 vaccine trial, saying that in this interim
1:35.1	look, the vaccine showed to be more than 90% effective in preventing COVID-19 cases.
1:41.9	Now this is the first look we're getting at any of these
1:43.8	efficacy studies of COVID-19 vaccines and it is much higher than analysts had been
1:49.2	expecting or modeling.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.